Atp6ap2 ablation in adult mice impairs viability through multiple organ deficiencies

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Wendling, Olivia ^a   Champy, Marie France ^a   Jaubert, Solène ^b   Pavlovic, Guillaume ^a   Dubos, Aline ^a,c,d,e,f   Lindner, Loic ^a   Jacobs, Hugues ^a   Mark, Manuel ^a,c,d,e,f   Combe, Roy ^a   Da Cruz, Isabelle Goncalves ^a   Luche, Hervé ^f   Mudgett, John S ^g   Rosahl, Thomas ^g   Sorg, Tania ^a   Malissen, Marie ^b   Reilly, Patrick T ^a   Hérault, Yann ^a,c,d,e,f  

^a INSTITUT CLINIQUE DE LA SOURIS   (France)

^b Aix Marseille University UMS3367   (France)

^c INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^d CNRS   (France)

^e INSERM   (France)

^f UNIVERSITÉ DE STRASBOURG   (France)

^g MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATP6AP2 PROTEIN, MOUSE; CELL SURFACE RECEPTOR; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATASE;

ANIMAL; DEFICIENCY; GENE KNOCKOUT; MORTALITY; MOUSE; MULTIPLE ORGAN FAILURE; PATHOLOGY; SURVIVAL ANALYSIS;

ANIMALS; GENE KNOCKOUT TECHNIQUES; MICE; MULTIPLE ORGAN FAILURE; PROTON-TRANSLOCATING ATPASES; RECEPTORS, CELL SURFACE; SURVIVAL ANALYSIS;

EID: 85028469036     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-08845-7     Document Type: Article

References (57)

1. Burckle, C. & Bader, M. Prorenin and its ancient receptor. Hypertension 48, 549-551, doi: 10. 1161/01. HYP. 0000241132. 48495. df (2006).
2. Rousselle, A., Sihn, G., Rotteveel, M. & Bader, M. (Pro)renin receptor and V-ATPase: from Drosophila to humans. Clin Sci (Lond) 126, 529-536, doi: 10. 1042/CS20130307 (2014).
3. Ichihara, A. et al. Nonproteolytic activation of prorenin contributes to development of cardiac fibrosis in genetic hypertension. Hypertension 47, 894-900, doi: 10. 1161/01. HYP. 0000215838. 48170. 0b (2006).
4. Nguyen, G. et al. Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest 109, 1417-1427, doi: 10. 1172/JCI14276 (2002).
5. Rafiq, K., Mori, H., Masaki, T. & Nishiyama, A. (Pro)renin receptor and insulin resistance: possible roles of angiotensin II-dependent and-independent pathways. Mol Cell Endocrinol 378, 41-45, doi: 10. 1016/j. mce. 2012. 05. 016 (2013).
6. Kaneshiro, Y. et al. Increased expression of cyclooxygenase-2 in the renal cortex of human prorenin receptor gene-transgenic rats. Kidney Int 70, 641-646, doi: 10. 1038/sj. ki. 5001627 (2006).
7. Ichihara, A. et al. Prorenin receptor blockade inhibits development of glomerulosclerosis in diabetic angiotensin II type 1a receptordeficient mice. J Am Soc Nephrol 17, 1950-1961, doi: 10. 1681/ASN. 2006010029 (2006).
8. Lu, Y. et al. ZT-25, a new vacuolar H-ATPase inhibitor, induces apoptosis and protective autophagy through ROS generation in HepG2 cells. Eur J Pharmacol 771, 130-138, doi: 10. 1016/j. ejphar. 2015. 12. 026 (2015).
9. Ochotny, N., Voronov, I., Owen, C., Aubin, J. E. & Manolson, M. F. The R740S mutation in the V-ATPase a3 subunit results in osteoclast apoptosis and defective early-stage autophagy. J Cell Biochem 114, 2823-2833, doi: 10. 1002/jcb. 24630 (2013).
10. Binger, K. J. & Muller, D. N. Autophagy and the (Pro)renin Receptor. Front Endocrinol (Lausanne) 4, 155, doi: 10. 3389/fendo. 2013. 00155 (2013).
11. Trepiccione, F. et al. Renal Atp6ap2/(Pro)renin Receptor Is Required for Normal Vacuolar H+-ATPase Function but Not for the Renin-Angiotensin System. J Am Soc Nephrol 27, 3320-3330, doi: 10. 1681/ASN. 2015080915 (2016).
12. EauClaire, S. F. et al. Mutations in vacuolar H+-ATPase subunits lead to biliary developmental defects in zebrafish. Dev Biol 365, 434-444, doi: 10. 1016/j. ydbio. 2012. 03. 009 (2012).
13. Buechling, T. et al. Wnt/Frizzled signaling requires dPRR, the Drosophila homolog of the prorenin receptor. Curr Biol 20, 1263-1268, doi: 10. 1016/j. cub. 2010. 05. 028 (2010).
14. Cruciat, C. M. et al. Requirement of prorenin receptor and vacuolar H+-ATPase-mediated acidification for Wnt signaling. Science 327, 459-463, doi: 10. 1126/science. 1179802 (2010).
15. Niehrs, C. & Boutros, M. Trafficking, acidification, and growth factor signaling. Sci Signal 3, pe26, doi: 10. 1126/scisignal. 3134pe26 (2010).
16. Hirose, T. et al. Association of (pro)renin receptor gene polymorphism with blood pressure in Japanese men: the Ohasama study. Am J Hypertens 22, 294-299, doi: 10. 1038/ajh. 2008. 357 (2009).
17. Ott, C. et al. Association of (pro)renin receptor gene polymorphism with blood pressure in Caucasian men. Pharmacogenet Genomics 21, 347-349, doi: 10. 1097/FPC. 0b013e328344cdd2 (2011).
18. Dai, F. F. et al. A Novel GLP1 Receptor Interacting Protein ATP6ap2 Regulates Insulin Secretion in Pancreatic Beta Cells. J Biol Chem 290, 25045-25061, doi: 10. 1074/jbc. M115. 648592 (2015).
19. Gupta, H. V., Vengoechea, J., Sahaya, K. & Virmani, T. A splice site mutation in ATP6AP2 causes X-linked intellectual disability, epilepsy, and parkinsonism. Parkinsonism & Related Disorders 21, 1473-1475, doi: 10. 1016/j. parkreldis. 2015. 10. 001 (2015).
20. Korvatska, O. et al. Altered splicing of ATP6AP2 causes X-linked parkinsonism with spasticity (XPDS). Hum Mol Genet 22, 3259-3268, doi: 10. 1093/hmg/ddt180 (2013).
21. Ramser, J. et al. A unique exonic splice enhancer mutation in a family with X-linked mental retardation and epilepsy points to a novel role of the renin receptor. Hum Mol Genet 14, 1019-1027, doi: 10. 1093/hmg/ddi094 (2005).
22. Jansen, E. J. et al. ATP6AP1 deficiency causes an immunodeficiency with hepatopathy, cognitive impairment and abnormal protein glycosylation. Nat Commun 7, 11600, doi: 10. 1038/ncomms11600 (2016).
23. Riediger, F. et al. Prorenin receptor is essential for podocyte autophagy and survival. J Am Soc Nephrol 22, 2193-2202, doi: 10. 1681/ASN. 2011020200 (2011).
24. Kinouchi, K. et al. The (pro)renin receptor/ATP6AP2 is essential for vacuolar H+-ATPase assembly in murine cardiomyocytes. Circ Res 107, 30-34, doi: 10. 1161/CIRCRESAHA. 110. 224667 (2010).
25. Dubos, A. et al. Conditional depletion of intellectual disability and Parkinsonism candidate gene ATP6AP2 in fly and mouse induces cognitive impairment and neurodegeneration. Hum Mol Genet, doi: 10. 1093/hmg/ddv380 (2015).
26. Song, R., Preston, G., Ichihara, A. & Yosypiv, I. V. Deletion of the prorenin receptor from the ureteric bud causes renal hypodysplasia. PLoS One 8, e63835, doi: 10. 1371/journal. pone. 0063835 (2013).
27. Geisberger, S. et al. New role for the (pro)renin receptor in T-cell development. Blood 126, 504-507, doi: 10. 1182/blood-2015-03-635292 (2015).
28. Kanda, A. et al. Atp6ap2/(pro)renin receptor interacts with Par3 as a cell polarity determinant required for laminar formation during retinal development in mice. J Neurosci 33, 19341-19351, doi: 10. 1523/JNEUROSCI. 1362-13. 2013 (2013).
29. Wu, C. H. et al. Adipocyte (Pro)Renin-Receptor Deficiency Induces Lipodystrophy, Liver Steatosis and Increases Blood Pressure in Male Mice. Hypertension 68, 213-219, doi: 10. 1161/HYPERTENSIONAHA. 115. 06954 (2016).
30. Ramkumar, N. et al. Nephron-specific deletion of the prorenin receptor causes a urine concentration defect. Am J Physiol Renal Physiol 309, F48-56, doi: 10. 1152/ajprenal. 00126. 2015 (2015).
31. Ramkumar, N. et al. Renal tubular epithelial cell prorenin receptor regulates blood pressure and sodium transport. Am J Physiol Renal Physiol 311, F186-194, doi: 10. 1152/ajprenal. 00088. 2016 (2016).
32. Dupe, V. et al. In vivo functional analysis of the Hoxa-1 3 retinoic acid response element (3RARE). Development 124, 399-410 (1997).
33. Seibler, J. et al. Rapid generation of inducible mouse mutants. Nucleic Acids Res 31, e12 (2003).
34. Gofflot, F. et al. Characterization and Validation of Cre-Driver Mouse Lines. Curr Protoc Mouse Biol 1, 1-15, doi: 10. 1002/9780470942390. mo100103 (2011).
35. Fleige, S. & Pfaffl, M. W. RNA integrity and the effect on the real-time qRT-PCR performance. Mol Aspects Med 27, 126-139, doi: 10. 1016/j. mam. 2005. 12. 003 (2006).
36. Sambrook, J. & Russell, D. Molecular Cloning: A Laboratory Manual. Vol. 3 (Cold Spring Harbor Laboratory Press, 2000).
37. Schefe, J. H., Lehmann, K. E., Buschmann, I. R., Unger, T. & Funke-Kaiser, H. Quantitative real-time RT-PCR data analysis: current concepts and the novel "gene expression's CT difference" formula. J Mol Med (Berl) 84, 901-910, doi: 10. 1007/s00109-006-0097-6 (2006).
38. Hameyer, D. et al. Toxicity of ligand-dependent Cre recombinases and generation of a conditional Cre deleter mouse allowing mosaic recombination in peripheral tissues. Physiol Genomics 31, 32-41, doi: 10. 1152/physiolgenomics. 00019. 2007 (2007).
39. Vooijs, M., Jonkers, J. & Berns, A. A highly efficient ligand-regulated Cre recombinase mouse line shows that LoxP recombination is position dependent. EMBO Rep 2, 292-297, doi: 10. 1093/embo-reports/kve064 (2001).
40. Su, A. I. et al. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci USA 101, 6062-6067, doi: 10. 1073/pnas. 0400782101 (2004).
41. Wu, C. et al. BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources. Genome Biol 10, R130, doi: 10. 1186/gb-2009-10-11-r130 (2009).
42. Shay, T. & Kang, J. Immunological Genome Project and systems immunology. Trends Immunol 34, 602-609, doi: 10. 1016/j. it. 2013. 03. 004 (2013).
43. Mark, M. et al. Histopathology in mouse metabolic investigations. Curr Protoc Mol Biol Chapter 29, Unit 29B 24, doi: 10. 1002/0471142727. mb29b04s78 (2007).
44. Lien, W. H. & Fuchs, E. Wnt some lose some: transcriptional governance of stem cells by Wnt/beta-catenin signaling. Genes Dev 28, 1517-1532, doi: 10. 1101/gad. 244772. 114 (2014).
45. Herbst, A. et al. Comprehensive analysis of beta-catenin target genes in colorectal carcinoma cell lines with deregulated Wnt/betacatenin signaling. BMC Genomics 15, 74, doi: 10. 1186/1471-2164-15-74 (2014).
46. Merlos-Suarez, A. et al. The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse. Cell Stem Cell 8, 511-524, doi: 10. 1016/j. stem. 2011. 02. 020 (2011).
47. Reya, T. et al. A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature 423, 409-414, doi: 10. 1038/nature01593 (2003).
48. Alrawi, S. J. et al. Aberrant crypt foci. Anticancer Res 26, 107-119 (2006).
49. Gupta, A. K. & Schoen, R. E. Aberrant crypt foci: are they intermediate endpoints of colon carcinogenesis in humans Curr Opin Gastroenterol 25, 59-65, doi: 10. 1097/MOG. 0b013e32831db286 (2009).
50. Khare, S., Chaudhary, K., Bissonnette, M. & Carroll, R. Aberrant crypt foci in colon cancer epidemiology. Methods Mol Biol 472, 373-386, doi: 10. 1007/978-1-60327-492-0-17 (2009).
51. Barker, N. et al. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 457, 608-611, doi: 10. 1038/nature07602 (2009).
52. Yanai, K. et al. Renin-dependent cardiovascular functions and renin-independent blood-brain barrier functions revealed by renindeficient mice. J Biol Chem 275, 5-8 (2000).
53. Tanimoto, K. et al. Angiotensinogen-deficient mice with hypotension. J Biol Chem 269, 31334-31337 (1994).
54. Chau, Y. Y. et al. Acute multiple organ failure in adult mice deleted for the developmental regulator Wt1. PLoS Genet 7, e1002404, doi: 10. 1371/journal. pgen. 1002404 (2011).
55. Kinouchi, K. et al. The role of individual domains and the significance of shedding of ATP6AP2/(pro)renin receptor in vacuolar H(+)-ATPase biogenesis. PLoS One 8, e78603, doi: 10. 1371/journal. pone. 0078603 (2013).
56. Cousin, C. et al. Soluble form of the (pro)renin receptor generated by intracellular cleavage by furin is secreted in plasma. Hypertension 53, 1077-1082, doi: 10. 1161/HYPERTENSIONAHA. 108. 127258 (2009).
57. Ichihara, A. et al. Possible roles of human (pro)renin receptor suggested by recent clinical and experimental findings. Hypertens Res 33, 177-180, doi: 10. 1038/hr. 2009. 214 (2010).